[HTML][HTML] Non-hospitalized adults with COVID-19 differ noticeably from hospitalized adults in their demographic, clinical, and social characteristics

SH Bergquist, C Partin, DL Roberts, JB O'Keefe… - SN Comprehensive …, 2020 - Springer
… SARS-CoV-2-positive non-hospitalized adults. We conducted a … patients treated in a COVID-19
virtual outpatient management clinic … of COVID-19 illness in non-hospitalized adults differ …

Oral nirmatrelvir for high-risk, nonhospitalized adults with Covid-19

J Hammond, H Leister-Tebbe, A Gardner… - … England Journal of …, 2022 - Mass Medical Soc
… , nonhospitalized adults at high risk for progression to severe coronavirus disease 2019 (Covid-19) …
Covid-19–related hospitalization or death from any cause through day 28, viral load, …

Hydroxychloroquine in nonhospitalized adults with early COVID-19: a randomized trial

CP Skipper, KA Pastick, NW Engen… - Annals of internal …, 2020 - acpjournals.org
… We enrolled nonhospitalized adults who were required to have 4 or fewer days of symptoms
and either PCR-confirmed SARS-CoV-2 infection or compatible symptoms after a high-risk …

[HTML][HTML] Antiviral and clinical activity of bamlanivimab in a randomized trial of non-hospitalized adults with COVID-19

KW Chew, C Moser, ES Daar, DA Wohl, JZ Li… - Nature …, 2022 - nature.com
… the virus that causes Coronavirus disease 2019 (COVID-19), … treatment of COVID-19 in
non-hospitalized persons 2,3,4,5 . … to moderate COVID-19 in non-hospitalized adults with risk …

Oral azvudine for mild‐to‐moderate COVID19 in high risk, nonhospitalized adults: Results of a real‐world study

H Yang, Z Wang, C Jiang, Y Zhang… - Journal of Medical …, 2023 - Wiley Online Library
… mild to moderate cases of COVID-19, resulting in a relatively … in COVID-19 patients. Therefore,
we suggested that, similar to nirmatrelvir, high-risk nonhospitalized adults with COVID-19

[HTML][HTML] Symptoms and risk factors for long COVID in non-hospitalized adults

A Subramanian, K Nirantharakumar, S Hughes… - Nature medicine, 2022 - nature.com
… for post-COVID-19 sequelae 27 . This analysis included both hospitalized and non-hospitalized
patients and two control groups consisting of patients without COVID-19 and those with …

Effectiveness of nirmatrelvir/ritonavir and molnupiravir in non-hospitalized adults with COVID-19: systematic review and meta-analysis of observational studies

YM Mesfin, JE Blais, KT Kibret… - Journal of …, 2024 - academic.oup.com
… and unvaccinated non-hospitalized adults with COVID-19. … treatment for COVID-19 in
non-hospitalized adults with data … of Science, WHO COVID-19 Research Database and medRxiv …

Efficacy and safety of molnupiravir for the treatment of non-hospitalized adults with mild COVID-19: a randomized, open-label, parallel-group phase 3 trial

SK Tippabhotla, DS Lahiri, C Kandi - 2022 - papers.ssrn.com
… to severe COVID-19. Non-hospitalized adults with mild COVID-19 were randomized to …
per the clinical guidance for management of adult COVID-19 patients by the Government of …

Phase 2/3 trial of molnupiravir for treatment of Covid-19 in nonhospitalized adults

Y Caraco, GE Crofoot, PA Moncada… - NEJM …, 2022 - evidence.nejm.org
Covid-19, 29 molnupiravir was observed to have a side-effect and AE profile that was not
dose-limiting in this small sample of nonhospitalized adults with Covid-19. … adults with Covid-19

Hydroxychloroquine for treatment of nonhospitalized adults with COVID19: A meta‐analysis of individual participant data of randomized trials

O Mitjà, G Reis, DR Boulware… - Clinical and …, 2023 - Wiley Online Library
… in hospitalized and non-hospitalized COVID-19 populations were rapidly initiated. Some of
these trials raised concerns regarding treatment safety in patients with COVID-19, particularly …